Twitter | Pretraživanje | |
Pretraživanje Osvježi
Grace E. Colón 1. velj
Reply Retweet Označi sa "sviđa mi se"
EBD Group 30. sij
Michelle Keefe, President of Commercial Solutions at explores what the year has in store for >>
Reply Retweet Označi sa "sviđa mi se"
Olderpreneurs 29. sij
Pacylex- Data from four different preclinical models suggest that PCLX-001 has robust efficacy in leukemia and lymphoma
Reply Retweet Označi sa "sviđa mi se"
Christina B Campbell 29. sij
Just as the team predicted at the media roundup at
Reply Retweet Označi sa "sviđa mi se"
Lou Regla 29. sij
The virtual liver will be the biotech breakthrough of the 2020s. Much like a real liver performing vital life functions but 100% scalable in the cloud.
Reply Retweet Označi sa "sviđa mi se"
CG Life 29. sij
Another interview is up! Hear Michelle Keefe, President of Commercial Solutions , explore what the drug industry should do to tell patient stories about positive therapeutic impact. Plus, her 2020 outlook & more!
Reply Retweet Označi sa "sviđa mi se"
EBD Group 28. sij
Speaking at 2020, , of gives an update the company's progress with its investigational medicine, OV101 (gaboxadol) for the treatment of Angelman syndrome and Fragile X syndrome >>
Reply Retweet Označi sa "sviđa mi se"
CG Life 27. sij
Check out 's first interview with Dr. Jeremy Levin, Chairman & CEO . Dr. Levin discusses 2020 biotech investment, Ovid's progress with its investigational medicine for Angelman & Fragile X syndromes, & more!
Reply Retweet Označi sa "sviđa mi se"
EBD Group 27. sij
Discover what leaders and experts in both biotech and finance had to say during the busiest week in healthcare while attending and >>
Reply Retweet Označi sa "sviđa mi se"
AgeX Therapeutics 17. sij
AgeX Therapeutics Presenting at Four Conferences this month: > , Jan 13-15 during > PMWC 2020 Jan 21-24 > World Stem Cell Summit Jan 21-24 > Therapeutics Jan 28-30
Reply Retweet Označi sa "sviđa mi se"
Global Genes 17. sij
It was so incredible to hear about all of the new ways we can continue to advocate and educate for at this year's .
Reply Retweet Označi sa "sviđa mi se"
Mandy Jackson 16. sij
Thanks for inviting me and thank you to those who came to see us!
Reply Retweet Označi sa "sviđa mi se"
Andrew Dunn 16. sij
Super fun! Thanks for having me
Reply Retweet Označi sa "sviđa mi se"
Kari Bennett 16. sij
The media roundup at is becoming a staple for winding down week. Great discussion w/ industry journalists
Reply Retweet Označi sa "sviđa mi se"
Bayer Pharma 16. sij
”At Leaps we also consider venture investment to be a marathon, not a sprint. We strongly believe in 4-6 years as an investment horizon to advance true breakthroughs rather than quick wins“, said Juergen Eckhardt, Head of
Reply Retweet Označi sa "sviđa mi se"
EuropaBio 16. sij
Rounding up three exciting days of during with a panel discussing different issues and trends that unfolded during the week
Reply Retweet Označi sa "sviđa mi se"
Johnson & Johnson Innovation 15. sij
Sanjay Mistry highlights incubation model is no strings attached, offering mentorship, expertise, & a “community of companies” of shared learning among residents.
Reply Retweet Označi sa "sviđa mi se"
Johnson & Johnson Innovation 15. sij
Today at , top investors, including ’s , reflect on the excitement of investing vs the reality & challenges innovators face in bringing new medicines to patients.
Reply Retweet Označi sa "sviđa mi se"
UPMC Enterprises 15. sij
. is one of the top funded universities in the world and at we are always looking to reinvent how we deliver care. So we are able to take the cutting edge of science and run it through our internal engine in order to spur growth.
Reply Retweet Označi sa "sviđa mi se"
Johnson & Johnson Innovation 15. sij
In step with the rapid transformation of startup business models, seed financing continues to evolve. Join Head Sanjay Mistry today to learn more about key changes that can impact life science innovators in 2020.
Reply Retweet Označi sa "sviđa mi se"